EquityZen is a marketplace for shares of proven pre IPO tech companies. Metabolon develops analytical methods and software for biomarker discovery by using metabolomics. Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics.
It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine.
The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. Metabolon was founded in and headquartered in Durham, North Carolina. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase. Request Access. Editor's Note: This article covers one or more microcap stocks. Please be aware of the risks associated with these stocks. Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it. The author has no business relationship with any company whose stock is mentioned in this article.
WallStArb 43 Followers. This article was written by. Trained at Goldman Sachs as an analyst and then did fixed-income and multi-strategy arbitrage for hedge fund Mariner Investment Group before starting his own hedge fund. Specialize in special situations and market neutral quantitative strategies. Is this happening to you frequently? Please report it on our feedback forum.
|Binary options english||Business cycle value investing formula|
|Kuasa forex pdf files||Filter for forex|
|Metabolon ipo||Forex plaat foto|
|Forex forecast for gas||The author has no business relationship with any company whose stock is mentioned in this article. Request Access. It appears that the risk appetite is back and investors are champing at the bit for quality biotech stories with promising futures. Is this happening to you frequently? The author is not receiving compensation for it. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured link. BostonGene BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.|
|Metabolon ipo||Request Access. About Metabolon Stock Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. View More Companies. Please disable your ad-blocker and refresh. EquityZen helps investors to access private companies and their employees to sell shares.|
|Mint impact investing fund||Long term forex analysis daily|
All Broker Reviews. Workers Comp. Invest in Art. Invest in Land. Invest in Real Estate. Invest in Wine. Invest in Gold. Find a Mortgage Broker. How to Invest in Artwork. Best Alternative Investments. Best Alternative Investment Platforms. Crypto Get Started. Is Bitcoin a Good Investment? Is Ethereum a Good Investment? What is Blockchain. Best Altcoins. How to Buy Cryptocurrency?
Crypto and DeFi What is DeFi? Decentralized Exchanges. Best DeFi Yield Farms. NFT Release Calendar. CryptoPunks Watchlist. Best Crypto Apps. Best Crypto Portfolio Trackers. Best Crypto Day Trading Strategies. Best Crypto IRA. Best Cryptocurrency Scanners. Best Business Crypto Accounts. Best Crypto Screeners. Cannabis News. TV YouTube. Trading School. My Stocks. Tools Calendars. Analyst Ratings Calendar. Dividend Calendar. Conference Call Calendar. Earnings Calendar. Economic Calendar.
FDA Calendar. Guidance Calendar. IPO Calendar. Retail Sales Calendar. SPAC Calendar. Stock Split Calendar. Trade Idea Feed. Analyst Ratings. Unusual Options Activity. Most Shorted. Largest Increase. Largest Decrease. Margin Calculator. Their latest acquisition was Metabolomic Discoveries on September 05, Novadrug is a drug discovery company geared toward the identification of effective antimicrobial, antiviral, immunosuppressive and anticancer drugs.
Celecure AS does drug discovery and development of anticancer drugs. Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors GPCRs. Heptares StaR Stabilized Receptor technology enables thermo-stabilization of GPCRs, a breakthrough allowing X-ray crystallography of conformationally-constrained receptors, thereby facilitating structure-based drug design at GPCRs that have been resistant to traditional methods of drug screening.
Xention is a Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs. The Company has potential breakthrough drugs for atrial fibrillation, an area in which it has developed considerable expertise.
Visiopharm is a provider of quantitative image analysis software and end-to-end Digital Pathology solutions for Hospitals, biopharmaceutical companies, and research institutions around the world. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
Deal Terms 7. Date Round Amount Investors Valuation. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. Subscribe to see more. Round Funding Date.
Metabolon Acquisitions 2 Acquisitions Metabolon acquired 2 companies. Date Investment Stage Companies Valuation. Metabolomic Discoveries. You May Also Like N. Novadrug Novadrug is a drug discovery company geared toward the identification of effective antimicrobial, antiviral, immunosuppressive and anticancer drugs. Celecure Celecure AS does drug discovery and development of anticancer drugs.
North Carolina's Metabolon, whose booming biomarker business has triggered rapid expansion, has raised $ million in a fourth round of financing and is. Morrisville-based precision health company Metabolon has just closed the books on $72 million in new combined debt and equity financing. Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling.